Manufacturing of Gene Therapeutics, G. Subramanian
Автор: Howard Название: RNA Interference from Biology to Therapeutics ISBN: 1461447437 ISBN-13(EAN): 9781461447436 Издательство: Springer Рейтинг: Цена: 28734.00 р. Наличие на складе: Есть у поставщика Поставка под заказ.
Описание: This volume addresses the role of different RNAi molecules in cellular processes as rational for diagnostic and therapeutic approaches. It covers RNAi therapeutic design to optimize siRNA potency and reduce off-target effects.
Автор: Steven J. Shire; Wayne Gombotz; Karoline Bechtold- Название: Current Trends in Monoclonal Antibody Development and Manufacturing ISBN: 1461424917 ISBN-13(EAN): 9781461424918 Издательство: Springer Рейтинг: Цена: 28732.00 р. Наличие на складе: Есть у поставщика Поставка под заказ.
Описание: This volume provides an understanding of the development, manufacturing techniques, and requirements of monoclonal antibodies. Covering one of the fastest growing areas of drug development, readers will find an informative text that describes the parameters for a successful regulatory submission.
Описание: With details of recent progress in HBOC research along with emerging products, this in-depth treatment surveys the scientific and clinical fundamentals. It evaluates the literature on safety and efficacy and predicts the most likely forthcoming advances.
Автор: Ebenezer Ivor Название: Neuropsychopharmacology and Therapeutics ISBN: 1118385659 ISBN-13(EAN): 9781118385654 Издательство: Wiley Рейтинг: Цена: 7912.00 р. Наличие на складе: Есть у поставщика Поставка под заказ.
Описание: Neuropsychopharmacology is a relatively new subject area in the neurosciences.
Автор: Sylvain Celanire; Sonia Poli Название: Small Molecule Therapeutics for Schizophrenia ISBN: 3319115014 ISBN-13(EAN): 9783319115016 Издательство: Springer Рейтинг: Цена: 16769.00 р. Наличие на складе: Есть у поставщика Поставка под заказ.
Описание:
Antipsychotics and the Dopamine-Serotonin Connection.- GLYT1 Inhibitors: From Hits to Clinical Candidates.- Metabotropic Glutamate Receptor 2 Activators.- Activation of the mGlu5 Receptor for the Treatment of Schizophrenia and Cognitive-Deficit-Associated Disorders.- Muscarinic Acetylcholine Receptor Activators.- Nicotinic Acetylcholine Receptor Modulators.- The Use of PDE10A and PDE9 Inhibitors for Treating Schizophrenia.
ООО "Логосфера " Тел:+7(495) 980-12-10 www.logobook.ru